08.10.2013 Aufrufe

Ressortforschungsberichte zur kerntechnischen Sicherheit und zum ...

Ressortforschungsberichte zur kerntechnischen Sicherheit und zum ...

Ressortforschungsberichte zur kerntechnischen Sicherheit und zum ...

MEHR ANZEIGEN
WENIGER ANZEIGEN

Erfolgreiche ePaper selbst erstellen

Machen Sie aus Ihren PDF Publikationen ein blätterbares Flipbook mit unserer einzigartigen Google optimierten e-Paper Software.

Reference:<br />

First author (year)<br />

Area of<br />

study<br />

Type of study Diagnosis of patients treated<br />

with ionising radiation<br />

Michel et al., 1997 France Cohort study Leukaemia (AML)<br />

Benyunes et al., 1995 Seattle, USA Cohort study BMT in aplastic anaemia,<br />

leukaemia, lymphoma and<br />

other diagnoses<br />

Tichelli et al., 1993<br />

and 1994<br />

Calissendorff et al.,<br />

1993<br />

Dunn et al., 1993 Baltimore<br />

and Atlanta,<br />

USA<br />

Ozsahin et al., 1992<br />

and 1994<br />

Switzer-land Prospective<br />

controlled<br />

cohort study<br />

Sweden Prospective<br />

cohort study<br />

Case control<br />

study<br />

BMT in aplastic anaemia,<br />

leukaemia, lymphoma and<br />

other diagnoses<br />

BMT in leukaemia, severe<br />

aplastic anaemia, and other<br />

diagnoses<br />

BMT in aplastic anaemia,<br />

leukaemia, lymphoma and<br />

other diagnoses (in four<br />

treatment groups); n=40 cases<br />

with cataract<br />

France Cohort study BMT in leukaemia, lymphoma,<br />

Non-Hodgkin<br />

lymphoma, multiple myeloma<br />

and other diagnoses;<br />

Bray et al. 1991 UK Cohort study BMT in various haematological<br />

malignancies<br />

Van Weel-Sipman et<br />

al., 1990<br />

Nether-lands Cohort study Hematological malignancy<br />

Livesey et al., 1989 UK Comparative<br />

clinical study<br />

BMT in leukaemia and<br />

aplastic anaemia<br />

Number<br />

irradiated<br />

patients<br />

n=19<br />

irradiated<br />

n=407 treated<br />

with TBI and<br />

chemotherapy<br />

Control group definition Number nonirradiated<br />

controls<br />

Same diagnosis, but nonirradiated<br />

Same diagnosis, but<br />

only conditioned with<br />

chemotherapy<br />

n=164 Same diagnosis, but<br />

only conditioned with<br />

chemotherapy<br />

n=43<br />

leukaemia pat.<br />

condit. with<br />

TBI and<br />

chemotherapy<br />

other<br />

assignment<br />

Patients with severe aplastic<br />

anaemia conditioned only<br />

with chemotherapy<br />

Same diagnosis, cataractfree<br />

controls; n=326<br />

– 114 –<br />

Recruitment<br />

period<br />

Follow-up<br />

period<br />

n=26 1986-1992 Mean<br />

follow-up<br />

5.9 years<br />

n=85 Not stated Median: 6<br />

years<br />

(range 2-<br />

18)<br />

n=33 1979-1991 At least<br />

180 days<br />

n=9<br />

other<br />

assignment<br />

1978-1989<br />

Median: 5<br />

years<br />

(range 1-<br />

10)<br />

1978-1991 Until June<br />

1992<br />

n=157 - - Recruited 1986-<br />

1989<br />

n=30 treated<br />

with TBI<br />

n=27<br />

survivors<br />

Same diagnosis, but nonirradiated<br />

Until July<br />

1992<br />

n=11 1983-1989 6-84<br />

months<br />

- - 1980-1988 Up to 8<br />

years<br />

n=27 Same diagnosis and one<br />

non-Hodgkin lymphoma,<br />

but non-irradiated<br />

n=7 1983-1988 5-63<br />

months<br />

Type of ionising radiation<br />

applied in irradiated group<br />

(as given in the paper)<br />

TBI<br />

TBI; dual opposing Co-60<br />

sources<br />

TBI with linear accelerator<br />

TBI with linear accelerator at a<br />

mean dose of 0.04 Gy/min.<br />

TBI<br />

Before 1989 6-MV X-ray<br />

linear accelerator, then a<br />

cobalt-60 telecobalt unit<br />

Linear accelerator with midline<br />

tissue dose rate of 0-25<br />

Gy/min.<br />

TBI with linear accelerator<br />

TBI

Hurra! Ihre Datei wurde hochgeladen und ist bereit für die Veröffentlichung.

Erfolgreich gespeichert!

Leider ist etwas schief gelaufen!